Terms: = Thyroid cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Diagnosis
11 results:
1. Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy.
Kalchiem-Dekel O; Falcon CJ; Bestvina CM; Liu D; Kaplanis LA; Wilhelm C; Eichholz J; Harada G; Wirth LJ; Digumarthy SR; Lee RP; Kadosh D; Mendelsohn RB; Donington J; Gainor JF; Drilon A; Lin JJ
J Thorac Oncol; 2022 Sep; 17(9):1130-1136. PubMed ID: 35788405
[TBL] [Abstract] [Full Text] [Related]
2. Differences in the dielectric properties of various benign and malignant thyroid nodules.
Huang S; Cai W; Han S; Lin Y; Wang Y; Chen F; Shao G; Liu Y; Yu X; Cai Z; Zou Z; Yao S; Wang Q; Li Z
Med Phys; 2021 Feb; 48(2):760-769. PubMed ID: 33119125
[TBL] [Abstract] [Full Text] [Related]
3. [Clinicopathologic features of cystic hypersecretory lesion of the breast].
Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X
Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245
[TBL] [Abstract] [Full Text] [Related]
4. Detection of cervical metastatic lymph nodes in papillary thyroid carcinoma by Fourier transform infrared spectroscopy.
Liu Y; Xu Y; Liu Y; Zhang Y; Wang D; Xiu D; Xu Z; Zhou X; Wu J; Ling X
Br J Surg; 2011 Mar; 98(3):380-4. PubMed ID: 21254012
[TBL] [Abstract] [Full Text] [Related]
5. [Differentiated thyroid carcinoma--how to improve the long-term results? Twenty-five-year outcomes of 850 patients].
Melliere D; Hindie E; Becquemin JP; Desgranges P; Allaire E; Geachan E
Bull Acad Natl Med; 2006 Jan; 190(1):89-106; discussion 106-9. PubMed ID: 16878448
[TBL] [Abstract] [Full Text] [Related]
6. Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma.
Yamamoto J; Ohshima K; Nabeshima K; Ikeda S; Iwasaki H; Kikuchi M
Oncol Rep; 2004 Apr; 11(4):825-31. PubMed ID: 15010880
[TBL] [Abstract] [Full Text] [Related]
7. DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy.
Smith-Jones PM; Bischof C; Leimer M; Gludovacz D; Angelberger P; Pangerl T; Peck-Radosavljevic M; Hamilton G; Kaserer K; Kofler A; Schlangbauer-Wadl H; Traub T; Virgolini I
Endocrinology; 1999 Nov; 140(11):5136-48. PubMed ID: 10537142
[TBL] [Abstract] [Full Text] [Related]
8. [Chest X ray: routine indication in the follow-up of differentiated thyroid cancer?].
Lorenzen J; Beese M; Mester J; Brumma K; Beyer W; Clausen M
Nuklearmedizin; 1998; 37(6):208-12. PubMed ID: 9770715
[TBL] [Abstract] [Full Text] [Related]
9. [Anaplastic carcinoma of the thyroid. Our experience].
Nicolosi A; Addis E; Massidda B; Malloci A; Mura E; Esu S
Minerva Chir; 1992 Jul; 47(13-14):1161-7. PubMed ID: 1508369
[TBL] [Abstract] [Full Text] [Related]
10. Radiotherapeutic management of primary thyroid lymphoma.
Blair TJ; Evans RG; Buskirk SJ; Banks PM; Earle JD
Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):365-70. PubMed ID: 3918965
[TBL] [Abstract] [Full Text] [Related]
11. [Early diagnosis of malignant thyroid neoplasms].
Wildmeister W
Fortschr Med; 1977 Apr; 95(14):923-30. PubMed ID: 852808
[TBL] [Abstract] [Full Text] [Related]